Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection. - Wikidata - awgldk - TriplyDB

Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection.

Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection.

http://www.wikidata.org/entity/Q37645860

about

Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins Cobalt Zinc Ferrite Nanoparticles as a Potential Magnetic Resonance Imaging Agent: An In vitro Study.Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer.Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma The role of biomarkers in the management of epithelial ovarian cancer.Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.Magnetic Iron Oxide Nanoparticles as T2 MR Imaging Contrast Agent for Detection of Breast Cancer (MCF-7) Cell.Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.Recent advances in nanomedicine and survivin targeting in brain cancers.Targeted Superparamagnetic Iron Oxide Nanoparticles for In Vivo Magnetic Resonance Imaging of T-Cells in Rheumatoid Arthritis.In vitro Study of SPIONs-C595 as Molecular Imaging Probe for Specific Breast Cancer (MCF-7) Cells Detection

P2860

Q28077999-06AD0AB9-DE94-48BF-AE15-A506F1B28F31 Q30978421-0623BF67-8680-45CE-91AD-A9B5DF62FBC0 Q31151661-46793E86-B173-468C-AB20-04B6819DFB77 Q35375637-AE56A67A-14D8-4250-962B-F2A36F42E23E Q39281140-81B0D83B-54DF-44C7-8551-D5064143803D Q41850545-DDC15F1A-F29A-47BD-AED6-9F4F72A0260D Q43582691-8AA6A9C4-71B6-4486-B4D0-775B81FE38C9 Q47150078-08935B41-4DC7-4670-93F4-7E05666DE3A0 Q47378913-320D5599-3149-4DF0-B7E5-FABC882EE377 Q48599820-F3A0C1F9-5755-4601-B635-E37DAA68B022 Q57182129-097AC520-4525-4BBB-8A87-B628273B81DF

P2860

Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection.

http://www.wikidata.org/entity/Q37645860

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Superparamagnetic iron oxide-C ...... for ovarian cancer detection.

@en

Superparamagnetic iron oxide-C ...... for ovarian cancer detection.

@nl

type

label

Superparamagnetic iron oxide-C ...... for ovarian cancer detection.

@en

Superparamagnetic iron oxide-C ...... for ovarian cancer detection.

@nl

prefLabel

Superparamagnetic iron oxide-C ...... for ovarian cancer detection.

@en

Superparamagnetic iron oxide-C ...... for ovarian cancer detection.

@nl

P1433

Q37645860-A668D533-C28F-4F43-B02A-46D3C03FD6E7

P1476

Q37645860-B586EA18-DFC0-4BD8-84CB-28CFE22D0890

P2093

Q37645860-874B0271-8071-460F-ACB9-5CE05456047D

Q37645860-B5A26F39-0841-4DFD-A74A-5888A1248879

P2860

Q37645860-1D346520-83F5-4B79-999A-EBD37EAF772B

Q37645860-3F6CA298-B991-457E-A8EC-5582768D84EB

Q37645860-418B63AA-DEA3-41D1-AA9E-2DACE32D81BD

Q37645860-61AACB47-DF4E-400B-8E83-71EB0E68BC35

Q37645860-A360F074-4A8E-4F93-8FA1-021E2E7AC835

Q37645860-AD81D506-712A-44D3-AA38-F8DAB68D7390

Q37645860-B1E42A21-CCDD-414B-8205-9594BE8C7346

Q37645860-B8252C9C-5C40-40D8-B198-79428F61F278

Q37645860-C782F1B4-CA2F-4C0C-90E0-65214B758AFF

Q37645860-F6D89EFE-457D-4511-AE6A-DA3C2A58542F

P304

Q37645860-3597FEE9-5996-47E3-93B0-C9C57FE6323D

P31

Q37645860-7C1AB5BC-DC2B-4899-9DAC-B78BA1FFB7FC

P356

Q37645860-6900F0DF-A96E-447C-9DA4-18793A001DFF

P433

Q37645860-D0D11D31-65BB-49E4-A7A5-4B01C35AEB5A

P478

Q37645860-0E53B8F8-A598-446F-B243-718D5BE90ECB

P50

Q37645860-BCA7A80B-9301-460F-BF55-C0EC41D784D3

Q37645860-D016C282-0314-4261-8F54-C10C5E700297

P577

Q37645860-9C6B396B-357F-48E1-B640-8796D75C517D

P5875

Q37645860-E5967305-8E99-457B-9C8C-5C4DF3ABC92C

P698

Q37645860-51B6B5CF-7CDC-448B-B58F-17A68F308480

P921

Q37645860-BFE2A445-EB25-4B3B-BE04-0DD6B04B1337

P932

Q37645860-C3E6F014-B56C-4ACE-A949-EF7DE94B6315

P356

0971-6203.121198

P1433

Journal of Medical Physics

P1476

Superparamagnetic iron oxide-C ...... s for ovarian cancer detection

@en

P2093

Daryoush Shahbazi-Gahrouei

http://www.w3.org/2001/XMLSchema#string

Mohammad Abdolahi

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma.

In vitro studies of gadolinium-DTPA conjugated with monoclonal antibodies as cancer-specific magnetic resonance imaging contrast agents.

Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications

Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer

Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen

Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer.

Modification of MR molecular imaging probes with cysteine-terminated peptides and their potential for in vivo tumour detection.

Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model.

Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages

Novel MR imaging contrast agents for cancer detection.

P304

198-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0971-6203.121198

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Mohammad Abdolahi

Daryoush Shahbazi-Gahrouei

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258514762

http://www.w3.org/2001/XMLSchema#string

P698

24672155

http://www.w3.org/2001/XMLSchema#string

P921

P932

3959000

http://www.w3.org/2001/XMLSchema#string